Global Intravitreal (IVT) Injectables Market by Type (Anti-VEGF, Corticosteroids, Antibiotics, Antivirals, Antifungals), By Application (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

                                          

                                                                                       
Market Overview:

The global intravitreal (IVT) injectables market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of eye diseases, rising geriatric population, and technological advancements in IVT injectables. Based on type, the anti-VEGF segment is expected to account for the largest share of the global IVT injectables market in 2018. This segment is projected to grow at a CAGR of 8.1% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to factors such as increasing incidence of age-related macular degeneration (AMD) and diabetic retinopathy (DR). Based on application, hospital pharmacies are expected to account for the largest share of the global IVT injectables market in 2018. This segment is projected grow at a CAGRof 7%.



Get Free Sample Report

Product Definition:

Intravitreal (IVT) Injectables are medications that are injected directly into the vitreous humor of the eye. They are used to treat various eye diseases, including macular degeneration, diabetic retinopathy, and retinal detachment. Intravitreal (IVT) Injectables can also be used to treat certain types of tumors that develop in or near the eye.

Anti-VEGF:

Anti-Vascular Endothelial Growth Factor (anti-VEGF) is a protein that inhibits the growth of endothelial cells. It works by decreasing the migration and proliferation of vascular endothelial cells. The most commonly used anti-VEGF drug is Eylea (aflibercept), which was approved in 2002 in the U.S.

Corticosteroids:

Corticosteroids are naturally occurring hormones that are found in the adrenal glands. Corticosteroid medications act by binding to intracellular receptors and inhibiting the action of stress-induced hormones. The most commonly used corticosteroid is called prednisolone, which is a type of hydrocortisone.

Application Insights:

Retail pharmacies held the largest share of the global IVT market in 2017. This can be attributed to growing awareness about access to healthcare and increasing disposable income levels in developing countries including India, China, Brazil, Mexico and so on. Moreover, rising incidences of retinal diseases such as macular degeneration (MD) have created a high demand for anti-vascular endothelial growth factor (anti-VEGF) drugs which are used for its treatment from retail pharmacies.

The hospital pharmacy segment is expected to grow at a lucrative rate during the forecast period owing to an increase in number of surgeries globally along with rising investments by governments across countries for building better hospitals with advanced facilities that include ophthalmic equipment stores.

Regional Analysis:

North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing prevalence of diabetic retinopathy are some factors responsible for its growth. Moreover, the availability of technologically advanced products is anticipated to drive regional growth over the forecast period.

Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to high unmet clinical needs coupled with a large patient base in emerging countries such as China and India. Furthermore, an increase in government initiatives for raising awareness levels about vision care programs will also support regional growth over the next eight years. For instance, Novartis AG & Co., announced that it has provided free access to patients living in Asia (excluding Japan) until December 31st 2018 with no out-of-pocket expenses involved under its Genentech Program (Genzyme Program). This program was launched after receiving regulatory approval from China FDA on October 25th 2018 (Novartis press release).

Growth Factors:

Increasing prevalence of eye disorders and blindness: The increasing prevalence of various eye disorders, such as age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma is expected to drive the demand for IVT injectables in the coming years. According to a study by The National Eye Institute, around 2 million people in the U.S. are affected by AMD, which is expected to increase threefold by 2050. This will create a significant demand for IVT injectables over the forecast period.
Growing awareness about advanced treatment options: There is an increasing awareness among patients regarding advanced treatment options for various eye diseases such as AMD and diabetic retinopathy. This has led to an increase in the adoption of IVT injections as a preferred mode of treatment over traditional treatments such as laser therapy or surgery.


Get Free Sample Report
Scope Of The Report
Report Attributes
Report Details
Report Title
Intravitreal (IVT) Injectables Market Research Report
By Type
Anti-VEGF, Corticosteroids, Antibiotics, Antivirals, Antifungals
By Application
Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, Others
By Companies
Regeneron Pharmaceuticals, Bausch & Lomb, Novartis, Allergan, Alimera Sciences, ThromboGenics, Bristol-Myers Squibb, Regeneron Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.

Global Intravitreal (IVT) Injectables Market Report Segments:
The global Intravitreal (IVT) Injectables market is segmented on the basis of:
Types
Anti-VEGF, Corticosteroids, Antibiotics, Antivirals, Antifungals
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
Regeneron Pharmaceuticals
Bausch & Lomb
Novartis
Allergan
Alimera Sciences
ThromboGenics
Bristol-Myers Squibb
Regeneron Pharmaceuticals



Get Free Sample Report

Highlights of The Intravitreal (IVT) Injectables Market Report:
The market structure and projections for the coming years.
Drivers, restraints, opportunities, and current trends of market.
Historical data and forecast.
Estimations for the forecast period 2030.
Developments and trends in the market.
By Type:
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals
By Application:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Others
Market scenario by region, sub-region, and country.
Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Intravitreal (IVT) Injectables Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
Correctly Positioning New Products
Market Entry Strategies
Business Expansion Strategies
Consumer Insights
Understanding Competition Scenario
Product & Brand Management
Channel & Customer Management
Identifying Appropriate Advertising Appeals



8 Reasons to Buy This Report
Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
Implemented Robust Methodology to Prepare the Report
Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
Provides Information About the Top-winning Strategies Implemented by Industry Players.
In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
Customization of the Report Available

Frequently Asked Questions?